Covid-19 infection and mortality: a physiologist's perspective enlightening clinical features and plausible interventional strategies.
作者信息
Abassi Zaid A, Skorecki Karl, Heyman Samuel Noam, Kinaneh Safa, Armaly Zaher
机构信息
Department of Physiology and Biophysics, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Laboratory Medicine, Rambam Medical Center, Haifa, Israel.
出版信息
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1020-L1022. doi: 10.1152/ajplung.00097.2020. Epub 2020 Mar 24.
Abstract
摘要
相似文献
1
Covid-19 infection and mortality: a physiologist's perspective enlightening clinical features and plausible interventional strategies.
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1020-L1022. doi: 10.1152/ajplung.00097.2020. Epub 2020 Mar 24.
2
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.
3
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11.
4
Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach.
Nefrologia (Engl Ed). 2020 May-Jun;40(3):213-216. doi: 10.1016/j.nefro.2020.04.006. Epub 2020 Apr 30.
5
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.
6
Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):637-639. doi: 10.1016/j.dsx.2020.05.022. Epub 2020 May 12.
7
COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity.
Int J Obes (Lond). 2020 Aug;44(8):1800-1802. doi: 10.1038/s41366-020-0624-5. Epub 2020 Jun 8.
8
The role of ACEIs/ARBs in COVID-19: Friend or foe?
Med Hypotheses. 2020 Sep;142:109810. doi: 10.1016/j.mehy.2020.109810. Epub 2020 May 5.
9
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Med Hypotheses. 2020 Oct;143:109893. doi: 10.1016/j.mehy.2020.109893. Epub 2020 May 30.
10
The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
Arq Bras Cardiol. 2020 Jun 1;114(5):817-822. doi: 10.36660/abc.20200273.
引用本文的文献
1
Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins.
Biomolecules. 2023 Mar 23;13(4):578. doi: 10.3390/biom13040578.
2
Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics.
Int J Mol Sci. 2023 May 8;24(9):8454. doi: 10.3390/ijms24098454.
3
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.
Mol Cell Biochem. 2023 Jul;478(7):1533-1559. doi: 10.1007/s11010-022-04610-1. Epub 2022 Nov 21.
4
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy.
Cancers (Basel). 2022 Aug 23;14(17):4074. doi: 10.3390/cancers14174074.
5
Nutraceutical prospects of against the infectious viruses.
Food Biosci. 2022 Dec;50:101977. doi: 10.1016/j.fbio.2022.101977. Epub 2022 Aug 30.
6
Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.
Molecules. 2022 Jul 29;27(15):4854. doi: 10.3390/molecules27154854.
7
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Biomedicines. 2022 Jul 18;10(7):1731. doi: 10.3390/biomedicines10071731.
8
Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.
Comput Struct Biotechnol J. 2022;20:2091-2111. doi: 10.1016/j.csbj.2022.04.010. Epub 2022 Apr 9.
9
discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery.
Future Virol. 2022 Mar;0(0). doi: 10.2217/fvl-2021-0309. Epub 2022 Apr 4.
10
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection.
J Am Soc Nephrol. 2022 Jul;33(7):1293-1307. doi: 10.1681/ASN.2021091209. Epub 2022 Mar 2.
本文引用的文献
1
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.
2
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
3
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
4
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
5
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.
Antiviral Res. 2020 Apr;176:104742. doi: 10.1016/j.antiviral.2020.104742. Epub 2020 Feb 10.
6
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.
7
Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin.
ChemMedChem. 2019 Mar 22;14(6):673-685. doi: 10.1002/cmdc.201800807. Epub 2019 Feb 20.
8
Post-transcriptional modification of pro-BNP in heart failure: is glycosylation and circulating furin key for cardiovascular homeostasis?
Eur Heart J. 2014 Nov 14;35(43):3001-3. doi: 10.1093/eurheartj/ehu381. Epub 2014 Sep 21.
9
BNP molecular forms and processing by the cardiac serine protease corin.
Adv Clin Chem. 2013;61:1-31. doi: 10.1016/b978-0-12-407680-8.00001-4.
10
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Hypertens Res. 2009 Jul;32(7):533-6. doi: 10.1038/hr.2009.74. Epub 2009 May 22.
Zotero 插件